0000731766-21-000004.txt : 20210208 0000731766-21-000004.hdr.sgml : 20210208 20210208171651 ACCESSION NUMBER: 0000731766-21-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210202 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210208 DATE AS OF CHANGE: 20210208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITEDHEALTH GROUP INC CENTRAL INDEX KEY: 0000731766 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 411321939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10864 FILM NUMBER: 21602476 BUSINESS ADDRESS: STREET 1: UNITEDHEALTH GROUP CENTER STREET 2: 9900 BREN ROAD EAST CITY: MINNEAPOLIS STATE: MN ZIP: 55343 BUSINESS PHONE: 9529361300 MAIL ADDRESS: STREET 1: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP/ DATE OF NAME CHANGE: 20000309 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP DATE OF NAME CHANGE: 19920703 8-K 1 unh-20210202.htm 8-K unh-20210202
0000731766false00007317662021-02-022021-02-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM 8-K
—————————————
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 2, 2021
—————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
—————————————
Delaware1-1086441-1321939
(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

UnitedHealth Group Center, 9900 Bren Road East,Minnetonka,Minnesota55343
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (952) 936-1300
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.01 par valueUNHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Election of Directors; Appointment of Certain Officers
On February 4, 2021, UnitedHealth Group Incorporated (“UnitedHealth Group” or the “Company”) announced Sir Andrew P. Witty has become Chief Executive Officer and a director of UnitedHealth Group and Dirk C. McMahon has become President and Chief Operating Officer of UnitedHealth Group.
Additional information regarding Sir Andrew and Mr. McMahon, including their experience over the past five years, is incorporated herein by reference to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Sir Andrew and Mr. McMahon do not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Compensatory Arrangements of Certain Officers and Directors

In connection with the transition described above, on February 3, 2021, the Board of Directors and the Compensation and Human Resources Committee of the Board, after considering market data, internal equity, advice from the Compensation Committee’s independent compensation consultant, and other factors, made the following changes to Sir Andrew’s compensation:
Approved an annual base salary of $1,500,000.
Entered into the attached amendment to his employment agreement, which is incorporated by reference.
Departure of Directors and Certain Officers

On February 2, 2021, Mr. David S. Wichmann retired as the Company’s Chief Executive Officer and member of the Board after playing an instrumental role leading, building and unifying UnitedHealth Group over its most pivotal two-plus decades of growth and diversification, successfully achieving the growth and performance goals set when he became Chief Executive Officer in 2017 and guiding the Company during the onset of the pandemic. Mr. Wichmann is continuing in a transition role through March 31, 2021. As a result of Mr. Wichmann’s lengthy and successful tenure with the Company, he has met the definition of retirement set forth in his previously granted equity awards, which will continue to vest in accordance with their terms, similar to equity awards granted to other employees. For a two-year period, Mr. Wichmann will also receive payments approximating his most recent base salary and non-equity incentive compensation award.
Item 9.01.    Financial Statements and Exhibits.
ExhibitDescription
104Cover Page Interactive Data File (formatted as Inline XBRL).



Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 8, 2021                 
UNITEDHEALTH GROUP INCORPORATED
By: /s/ Dannette L. Smith
Dannette L. Smith
Secretary to the Board of Directors

EX-5.02 2 exhibit502.htm EX-5.02 Document

Exhibit 5.02
AMENDED AND RESTATED EMPLOYMENT AGREEMENT

This Agreement is between Andrew Witty (“Executive”) and United HealthCare Services, Inc. (“UnitedHealth Group”), and is effective as of February 3, 2021 (the “Effective Date”). This Agreement’s purposes are to set forth certain terms of Executive’s employment by UnitedHealth Group or one of its affiliates and to protect UnitedHealth Group’s knowledge, expertise, customer relationships, and confidential information. Unless the context otherwise requires, “UnitedHealth Group” includes all its affiliated entities. This Agreement amends and restates the Employment Agreement dated March 9, 2018 between Executive and UnitedHealth Group.
1. Employment and Duties.
A.Employment. UnitedHealth Group hereby employs Executive, and Executive accepts employment, under this Agreement’s terms.
B.Title and Duties. Executive will be employed as Chief Executive Officer, UnitedHealth Group. Executive will perform such duties, and exercise such supervision and control, as are commonly associated with Executive’s position, as well as perform such other duties as are reasonably assigned to Executive. Executive will devote substantially all of Executive’s business time and energy to Executive’s duties. Executive will maintain operations in Executive’s area of responsibility and will make every reasonable effort to ensure that the employees within that area of responsibility act in compliance with applicable law and UnitedHealth Group’s Code of Conduct, as amended from time to time. Executive is subject to all of UnitedHealth Group’s employment policies and procedures (except as specifically superseded by this Agreement).
2.    Compensation and Benefits.
A.Base Salary. Executive’s annual base salary will be $1,500,000, less applicable withholdings and deductions, payable according to UnitedHealth Group’s regular payroll schedule. Periodic adjustments to Executive’s base salary may be made in UnitedHealth Group’s discretion.
B.Incentive Compensation. Executive will be eligible to participate in UnitedHealth Group’s incentive compensation plans in UnitedHealth Group’s discretion and in accordance with the plans’ terms and conditions. Executive’s target bonus potential will be 200% of annual base salary, subject to periodic adjustments in UnitedHealth Group’s discretion.
C.Annual Equity Awards. Executive will be eligible for annual stock-based awards in accordance with UnitedHealth Group’s governance policy and guideline amounts authorized by UnitedHealth Group’s Compensation and Human Resources Committee. For 2021, management will recommend that Executive be awarded an annual equity grant of $14,375,000 in the form of (i) Performance-



Based Restricted Stock Units for the 2021-2023 performance period with a value of $7,187,500, subject to the performance vesting criteria and other terms of the performance period, (ii) Restricted Stock Units with a value of $3,593,750, and (iii) Options with a FAS value of $3,593,750. Subject to the terms of the applicable equity award certificate and UnitedHealth Group’s applicable equity incentive plan, as amended, the Restricted Stock Units (other than the Performance-Based Restricted Stock Units) and Options will vest 25% on each anniversary date of the grant, over a four-year period.
Recommended annual grants will be reviewed by the Committee at a regularly scheduled quarterly meeting. The number of shares comprising any recommended grant will be calculated the day of the Committee meeting using the closing price of UnitedHealth Group stock on the day the calculation is made.
D.Employee Benefits. Executive will be eligible to participate in UnitedHealth Group’s employee welfare, retirement, and stock incentive plans on the same basis as other similarly situated executives, in accordance with the terms of the plans. Executive will be eligible for Paid Time Off in accordance with UnitedHealth Group’s policies. UnitedHealth Group reserves the right to amend or discontinue any plan or policy at any time in its sole discretion. In addition to the Company’s generally available benefits, UnitedHealth Group shall provide Executive, at UnitedHealth Group’s expense during the term of Executive’s employment, a $2 million face value term life insurance policy and a long term disability policy which covers 60% of base salary in the event of a qualifying long term disability, subject to the policy terms.
Executive may use UnitedHealth Group’s aircraft for reasonable business use. Executive may also use UnitedHealth Group’s aircraft for reasonable non-business use as determined in UnitedHealth Group’s sole discretion, provided that such use does not interfere with bona fide business of UnitedHealth Group, and provided, further, that Executive shall personally reimburse UnitedHealth Group for the full incremental costs associated with such non-business use as determined by applicable federal laws and federal agency rules and regulations. Executive will be responsible for any taxable income recognized by Executive in connection with the personal use of private aircraft and shall not be entitled to any tax gross up payments or other reimbursements with respect thereto.
3.    Termination of Employment.
A.By Mutual Agreement. The parties may terminate Executive’s employment at any time by mutual agreement.
B.By UnitedHealth Group without Cause. UnitedHealth Group may terminate Executive’s employment without Cause upon 90 days’ prior written notice.
C.By UnitedHealth Group with Cause. UnitedHealth Group may terminate Executive’s employment at any time for Cause. “Cause” means Executive’s (a) material failure to follow UnitedHealth Group’s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, UnitedHealth
2


Group’s Code of Conduct, as amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Executive’s employment, (e) material breach of this Agreement, or (f) conduct that is materially detrimental to UnitedHealth Group’s interests. UnitedHealth Group will, within 120 days of discovery of the conduct, give Executive written notice specifying the conduct constituting Cause in reasonable detail and Executive will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied. In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 120 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.
D.By Executive without Good Reason. Executive may terminate Executive’s employment at any time for any reason, including due to Executive’s retirement.
E.By Executive for Good Reason. Executive may terminate Executive’s employment for Good Reason, as defined below. Executive must give UnitedHealth Group written notice specifying in reasonable detail the circumstances constituting Good Reason, within 120 days of becoming aware of such circumstances, or such circumstances will not constitute Good Reason. If the circumstances constituting Good Reason are reasonably capable of being remedied, UnitedHealth Group will have 60 days to remedy such circumstances. “Good Reason” will exist if UnitedHealth Group takes any of the following actions, without Executive’s consent: (a) reduces Executive’s base salary or target bonus percentage other than in connection with a general reduction affecting a group of employees; (b) moves Executive’s primary work location more than 50 miles; (c) makes changes that substantially diminish Executive’s duties or responsibilities from that of Chief Executive Officer; or (d) makes changes to Executive’s reporting relationship that results in Executive not reporting to the Chairman of UnitedHealth Group.
F.Due to Executive’s Death or Disability. Executive’s employment will terminate automatically if Executive dies, effective as of the date of Executive’s death. UnitedHealth Group may terminate Executive’s employment due to Executive’s disability that renders Executive incapable of performing the essential functions of Executive’s job, with or without reasonable accommodation. Executive will not be entitled to Severance Benefits under Section 4 in the event of termination due to Executive’s death or disability.
4. Severance Benefits.
A.Circumstances under Which Severance Benefits Payable. Executive will be entitled to Severance Benefits only if Executive’s employment is terminated by UnitedHealth Group without Cause or if Executive terminates employment for Good Reason. Whether Executive has had a termination of employment will be determined in a manner consistent with the definition of “Separation from Service” under Section 409A of the Internal Revenue Code of 1986 and its accompanying regulations (“Section 409A”) and will be referred to herein as a “Termination.” For purposes of this Agreement, Executive will be considered to
3


have experienced a Termination as of the date that the facts and circumstances indicate that it is reasonably anticipated that Executive will provide no further services after such date or that the level of bona fide services that Executive is expected to perform permanently decreases to no more than 20% of the average level of bona fide services that Executive performed over the immediately preceding 36-month period In consideration of the Severance Benefits in this Agreement, Executive waives any payments or benefits to which Executive otherwise might be or become entitled under any UnitedHealth Group severance plan or program.
B.Severance Benefits. Subject to Section 4.C, Executive shall be entitled to the following Severance Benefits if Executive experiences a Termination under the circumstances described in Section 4.A above:
(i)Two times Executive’s annualized base salary as of Executive’s Termination.
(ii)Any bonus or incentive compensation paid or payable to Executive for the two most recent calendar years (excluding equity-related awards, payments under any long-term or similar benefit plan, or any other special or one-time bonus or incentive compensation payments).
(iii)$12,000 lump sum payment, minus applicable deductions, to offset costs of COBRA, which amount will be paid within 60 days following Termination.
(iv)Outplacement services consistent with those provided to similarly situated executives provided by an outplacement firm selected by UnitedHealth Group.
The Severance Benefits in Sections 4.B.(i)-(ii) will be paid out, minus applicable deductions, including deductions for tax withholding, in equal bi-weekly payments on the regular payroll cycle over the 24-month period following Executive’s Termination. Commencement of payments shall begin on the first payroll date that is at least 60 days after the date of Executive’s Termination (the “Starting Date”), provided that Executive has satisfied the requirement in Section 4.C. The first payment on the Starting Date shall include those payments that would have been previously paid if the payments of the severance compensation had begun on the first payroll date following the date of Executive’s Termination. Executive’s entitlement to the payments of the severance compensation described in Sections 4.B(i)-(ii) shall be treated as the entitlement to a series of separate payments for purposes of Section 409A.
If Executive is a “Specified Employee” (within the meaning of Section 409A and determined pursuant to procedures adopted by UnitedHealth Group) at the time of Executive’s Termination and any amount that would be paid to Executive during the six-month period following Termination constitutes “Deferred Compensation” (within the meaning of Section 409A), such amount shall not be paid to Executive until the later of (i) six months after the date of Executive’s Termination, and (ii) the payment date or commencement date specified in this Agreement for such payment(s). On the first regular payroll date following the expiration of such six-month period (or if Executive dies during the six-month period, the first payroll date following the death), all payments that were delayed
4


pursuant to the preceding sentence shall be paid to Executive in a single lump sum and thereafter all payments shall be made as if there had been no such delay. All Severance Benefits described in Section 4.B shall be paid by, and no further severance compensation shall be paid or payable after, December 31 of the second calendar year following the year in which Executive’s Termination occurs.
C.Separation Agreement and Release Required. In order to receive any Severance Benefits under this Agreement, Executive must timely sign a separation agreement and release of claims in a form determined by UnitedHealth Group in its discretion. UnitedHealth Group shall provide to Executive a form of separation agreement and release of claims no later than three (3) days following Executive’s date of Termination. If Executive does not timely execute and deliver to UnitedHealth Group such separation agreement and release, or if Executive does so, but then revokes it if permitted by and within the time required by applicable law, UnitedHealth Group will have no obligation to pay severance compensation to Executive.
5.    Property Rights, Confidentiality, Non-Disparagement, and Restrictive Covenants.
A.UnitedHealth Group’s Property.
i.Assignment. Executive hereby agrees to assign (both during and after his/her employment) and hereby assigns to UnitedHealth Group all rights, titles and interests Executive may have in any invention, computer program, discovery, idea, writing, improvement, process, technique or other works (collectively called "Intellectual Property") whether or not patentable or registrable under copyright or similar statutes, created or conceived by Executive, either alone or jointly with others, during Executive’s employment that:
(a) Relates in any manner to the actual or anticipated business, research, or development of UnitedHealth Group;
(b) Results from work assigned to or performed by Executive for UnitedHealth Group; and/or
(c) Is conceived of or made with the use of UnitedHealth Group systems, equipment, supplies, materials, facilities, computer programs, confidential information and/or trade secret information.
ii.Disclosure of Intellectual Property. Executive agrees to promptly disclose in writing to UnitedHealth Group (both during and after Executive’s employment) any interest Executive may have in any Intellectual Property created or conceived by Executive, either alone or jointly with others, during his/her employment. Executive will also promptly disclose in writing to UnitedHealth Group any interest Executive may have in any Intellectual Property created or conceived by Executive, either alone or jointly with others, prior to employment that relates to the actual or anticipated business, research, or development of UnitedHealth Group.
iii.Assignment/Transfer of Web Properties. Executive agrees to transfer and assign (both during and after employment), and does hereby assign to
5


UnitedHealth Group all rights, titles, and interests in and to any domain name or social media account (collectively called “Web Properties”) registered or owned by Executive that:
(a) Was registered with the intent to be used by UnitedHealth Group; and/or
(b) Relates in any manner to, or is used to comment on, the actual or anticipated business of UnitedHealth Group; and/or
(c) Contains a registered or common law trademark of UnitedHealth Group.
iv.Perfection of Assignment. Executive will at all times, even after termination of employment, do anything reasonably requested of Executive to enable UnitedHealth Group to access, patent, copyright or obtain any other form of protection for the Intellectual Property or Web Properties created, conceived, or registered by Executive, either alone or jointly with others.
v.Exclusions. Sections 5.A.i.-iv. do not apply to Intellectual Property that meets all of the following criteria:
(a)    No UnitedHealth Group equipment, supplies, facilities, proprietary or trade secret information was used in its creation;
(b)    The Intellectual Property was developed entirely on Executive’s own time;
(c)    At the time of conception or reduction to practice the Intellectual Property does not relate directly to UnitedHealth Group’s business, actual or anticipated research or development; and
(d)    The Intellectual Property does not result from any work performed by Executive for UnitedHealth Group.
vi.No Removal of Property. Executive may not remove from UnitedHealth Group’s premises any UnitedHealth Group records, documents, data or other property, in either original or duplicate form, except as necessary in the ordinary course of UnitedHealth Group’s business.
vii.Return of Property. Executive must immediately deliver to UnitedHealth Group, upon termination of employment, or at any other time at UnitedHealth Group’s request, all UnitedHealth Group property, including records, documents, data, and equipment, and all copies of any such property, including any records or data Executive prepared during employment.
B.Confidential Information. Executive will be given access to and provided with sensitive, confidential, proprietary and trade secret information (“Confidential Information”) in the course of Executive’s employment. Examples of Confidential Information include: inventions; new product or marketing plans; business strategies and plans; merger and acquisition targets; financial and pricing
6


information; computer programs, source codes, models and databases; analytical models; customer lists and information; and supplier and vendor lists and other information which is not generally available to the public. Executive agrees not to disclose or use Confidential Information, either during or after Executive’s employment with UnitedHealth Group, except as necessary to perform Executive’s UnitedHealth Group duties or as UnitedHealth Group may consent in writing.
C.Non-Disparagement. Executive agrees not to criticize, make any negative comments about or otherwise disparage UnitedHealth Group or those associated with it, whether orally, in writing or otherwise, directly or by implication, to any person or entity, including UnitedHealth Group customers or agents.
D.Restrictive Covenants. Executive agrees to the restrictive covenants in this Section in consideration of Executive’s employment and UnitedHealth Group’s promises in this Agreement, including providing Executive access to Confidential Information. The restrictive covenants in this Section apply during Executive’s employment and for 24 months following termination of employment for any reason. Executive agrees that Executive will not, without UnitedHealth Group's prior written consent, directly or indirectly, for Executive or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner or shareholder, or in any other individual or representative capacity, engage in any of the following activities:
i.Non-Solicitation. Executive will not:
(a)Solicit or conduct business with any business competitive with UnitedHealth Group from any person or entity: (1) who was a UnitedHealth Group provider or customer within the 12 months before Executive’s employment termination and with whom Executive had contact regarding UnitedHealth Group’s activity, products or services, or for whom Executive provided services or supervised employees who provided those services, or about whom Executive learned Confidential Information during employment related to UnitedHealth Group’s provision of products and services to such person or entity, or (2) was a prospective provider or customer UnitedHealth Group solicited within the 12 months before Executive’s employment termination and with whom Executive had contact for the purposes of soliciting the person or entity to become a provider or customer of UnitedHealth Group, or supervised employees who had those contacts, or about whom Executive learned Confidential Information during employment related to UnitedHealth Group’s provision of products and services to such person or entity;
(b)Raid, hire, employ, recruit or solicit any UnitedHealth Group employee or consultant who possesses Confidential Information of UnitedHealth Group to leave UnitedHealth Group to join a competitor;
7


(c)Induce or influence any UnitedHealth Group employee, consultant, or provider who possesses Confidential Information of UnitedHealth Group to terminate his, her or its employment or other relationship with UnitedHealth Group; or
(d)Assist anyone in any of the activities listed above.
ii.Non-Competition. Executive will not:
(a)Engage in or participate in any activity that competes, directly or indirectly, with any UnitedHealth Group activity, product or service that Executive engaged in, participated in, or had Confidential Information about during Executive’s last 36 months of employment with UnitedHealth Group; or
(b)Assist anyone in any of the activities listed above.
iii.Geographic Scope.
(a)Executive’s obligations under this “Restrictive Covenants” section shall apply on a nationwide basis anywhere in the United States.
(b)Executive’s obligations under this “Restrictive Covenants” section shall also apply in any country outside the United States with respect to which Executive had responsibility for any UnitedHealth Group activity, product or service in that country.
iv.To the extent Executive and UnitedHealth Group agree at any time to enter into separate agreements containing restrictive covenants with different or inconsistent terms than those contained herein, Executive and UnitedHealth Group acknowledge and agree that such different or inconsistent terms shall not in any way affect or have relevance to the Restrictive Covenants contained herein.
Executive agrees that the provisions of this Section 5 are reasonable and necessary to protect the legitimate interests of UnitedHealth Group.
E.Cooperation and Indemnification. Executive agrees to cooperate fully (i) with UnitedHealth Group in the investigation, prosecution or defense of any potential claims or concerns regarding UnitedHealth Group’s business about which Executive has relevant knowledge, including by providing truthful information and testimony as reasonably requested by UnitedHealth Group, and (ii) with all government authorities on matters pertaining to any investigation, litigation or administrative proceeding concerning UnitedHealth Group. UnitedHealth Group will reimburse Executive for any reasonable travel and out-of-pocket expenses incurred by Executive in providing such cooperation. UnitedHealth Group will indemnify Executive, in accordance with the Delaware Business Corporation Act, for all claims and other covered matters arising in connection with Executive’s employment.
F.Injunctive Relief. Executive agrees that (a) legal remedies (money damages) for any breach of Section 5 will be inadequate, (b) UnitedHealth Group will suffer immediate and irreparable harm from any such breach, and (c) UnitedHealth
8


Group will be entitled to injunctive relief from a court in addition to any legal remedies UnitedHealth Group may seek in arbitration. If an arbitrator or court determines that Executive has breached any provision of Section 5, Executive agrees to pay to UnitedHealth Group its reasonable costs and attorney’s fees incurred in enforcing that provision
6.    Miscellaneous.
A.Tax Withholding. All compensation payable under this Agreement will be subject to applicable tax withholding and other required or authorized deductions.
B.Assignment. Executive may not assign this Agreement. UnitedHealth Group may assign this Agreement. Any successor to UnitedHealth Group will be deemed to be UnitedHealth Group under this Agreement.
C.Entire Agreement; Amendment. This Agreement contains the parties’ entire agreement regarding its subject matter and may only be amended in a writing signed by the parties. This Agreement supersedes any and all prior oral or written employment agreements (including letters and memoranda) between Executive and UnitedHealth Group or its predecessors. This Agreement does not supersede the terms of any stock option, restricted stock, or stock appreciation rights plan or award. Notwithstanding the terms of any other agreement heretofore or hereafter entered into between the parties that reference retirement, Executive and UnitedHealth Group acknowledge and agree that for purposes of calculating years of service for retirement eligibility, Executive will receive 3.7 years of service credit for each year Executive remains employed with UnitedHealth Group after February 3, 2021. In addition, prior to the date upon which Executive becomes eligible for retirement, if Executive’s employment is terminated by UnitedHealth Group without Cause or if Executive terminates employment for Good Reason, Executive will be deemed to have met the applicable age and service requirements and will be retirement eligible. UnitedHealth Group agrees that this revised retirement definition will be reflected in and become part of Executive’s outstanding and future issued equity award certificates.
D.Choice of Law. Minnesota law governs this Agreement.
E.Waivers; Other Rights. No party’s failure to exercise, or delay in exercising, any right or remedy under this Agreement will be a waiver of such right or remedy, nor will any single or partial exercise of any right or remedy preclude any other or further exercise of such right or remedy. Nothing in this Agreement prohibits Executive from making disclosures that are protected under law or reporting violations of state or federal law or regulation to governmental agencies or entities.
F.Narrowed Enforcement and Severability. If a court or arbitrator decides that any provision of this Agreement is invalid or overbroad, the parties agree that the court or arbitrator should narrow such provision so that it is enforceable or, if narrowing is not possible or permissible, such provision should be considered severed and the other provisions of this Agreement should be unaffected.
G.Dispute Resolution and Remedies. Except for injunctive relief under Section 5.F, any dispute between the parties relating to this Agreement or to Executive’s
9


employment will be resolved by binding arbitration under UnitedHealth Group’s Employment Arbitration Policy, as it may be amended from time to time. The arbitrator(s) may not vary this Agreement’s terms and must apply applicable law.
H.Payment of Deferred Compensation – Section 409A. To the extent applicable, it is intended that the compensation arrangements under this Agreement be in full compliance with Section 409A. This Agreement shall be construed in a manner to give effect to such intention. In no event whatsoever shall UnitedHealth Group be liable for any tax, interest or penalties that may be imposed on Executive under Section 409A. UnitedHealth Group shall have no obligation to indemnify or otherwise hold Executive harmless from any such taxes, interest or penalties, or from liability for any damages related thereto.
I.Electronic Transmission/Counterparts. The executed version of this Agreement may be delivered by facsimile or email, and upon receipt, such transmission shall be deemed delivery of an original. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original, and all of which together will constitute one document.
United HealthCare Services, Inc. Executive
By /s/ Patricia L. Lewis  /s/ Andrew P. Witty
ItsExecutive Vice President and
Chief Human Resources Officer
Date2/8/20212/8/2021
10
EX-101.SCH 3 unh-20210202.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 unh-20210202_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 unh-20210202_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 unh-20210202_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Document Information [Line Items] Document Information [Line Items] Amendment Flag Amendment Flag City Area Code City Area Code Entity Address, State or Province Entity Address, State or Province Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Tax Identification Number Entity Tax Identification Number Document [Domain] Document [Domain] Document Information, Document [Axis] Document Information, Document [Axis] Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Written Communications Written Communications Title of 12(b) Security Title of 12(b) Security Security Exchange Name Security Exchange Name Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Document Information [Table] Document Information [Table] EX-101.PRE 7 unh-20210202_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 unh-20210202_htm.xml IDEA: XBRL DOCUMENT 0000731766 2021-02-02 2021-02-02 0000731766 false 8-K 2021-02-02 UNITEDHEALTH GROUP INCORPORATED DE 1-10864 41-1321939 41-1321939 UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, MN 55343 952 936-1300 false false false false Common Stock, $.01 par value UNH NYSE false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover
Feb. 02, 2021
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Feb. 02, 2021
Entity Registrant Name UNITEDHEALTH GROUP INCORPORATED
Entity Incorporation, State or Country Code DE
Entity File Number 1-10864
Entity Tax Identification Number 41-1321939
Entity Address, Address Line One UnitedHealth Group Center, 9900 Bren Road East,
Entity Address, City or Town Minnetonka,
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55343
City Area Code 952
Local Phone Number 936-1300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.01 par value
Trading Symbol UNH
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000731766
Amendment Flag false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.unitedhealthgroup.com/role/Cover Cover Cover 1 false false All Reports Book All Reports unh-20210202.htm exhibit502.htm unh-20210202.xsd unh-20210202_cal.xml unh-20210202_def.xml unh-20210202_lab.xml unh-20210202_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "unh-20210202.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "unh-20210202_cal.xml" ] }, "definitionLink": { "local": [ "unh-20210202_def.xml" ] }, "inline": { "local": [ "unh-20210202.htm" ] }, "labelLink": { "local": [ "unh-20210202_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "unh-20210202_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "unh-20210202.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 27, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "unh", "nsuri": "http://www.unitedhealthgroup.com/20210202", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20210202.htm", "contextRef": "i2446bfaf1c37474480f744d4bf2efae3_D20210202-20210202", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.unitedhealthgroup.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "unh-20210202.htm", "contextRef": "i2446bfaf1c37474480f744d4bf2efae3_D20210202-20210202", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.", "label": "Document [Domain]", "terseLabel": "Document [Domain]" } } }, "localname": "DocumentDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_DocumentInformationDocumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Document Information, Document [Axis]", "terseLabel": "Document Information, Document [Axis]" } } }, "localname": "DocumentInformationDocumentAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.unitedhealthgroup.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0000731766-21-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000731766-21-000004-xbrl.zip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end